ISSN: 1734-1922
Archives of Medical Science Special Issues
Current issue Archive Archives of Medical Science
Search
3/2007
 
Share:
Send email
Share:
abstract:

Invited review
The rationale of metabolic treatment in ischaemic heart disease

Mario Marzilli
,
Maria Focardi
,
Silvia Affinito
,
Eugenia Capati
,
Rossella Urselli

Arch Med Sci 2007; 3, 3A: S25-S29
Online publish date: 2008/01/10
View full text Get citation
 
Ischaemic heart disease remains the leading cause of death in the western world and jeopardize quality of life in millions people. PTCA plus medical therapy can control symptoms in most patients with stable angina. However, many trials consistently report persistance of angina and/or ischemia in one third of patients. Awareness of the limited benefit from standard treatments is increasing and stimulates the search for innovative approaches. Improved understanding of cardiac energy metabolism offers promising alternatives and new solution to the problem. A partial shift from free fatty acid to glucose oxidations has been shown to improve cardiac efficiency and to increase tolerance to ischaemia. Large clinical trias based on metabolic agents are warranted.
keywords:

ischaemic heart disease, PTCA, stable angina
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.